Second-Line Combination Therapies in Pancreatic Cancer: Where Are We Now?

被引：4
|
作者：
Uccello, Mario [1 ]
Moschetta, Michele [1 ]
Arkenau, Hendrik-Tobias [1 ]
机构：
[1] Sarah Cannon Res Inst UK, London, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷 / 12期
关键词：
PACLITAXEL PLUS GEMCITABINE; TRIAL;
D O I：
10.1200/JCO.2016.71.0921
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1370 / +
页数：3
相关论文
共 50 条
  • [41] Immunomodulatory Second-Line Therapies for Immune Thrombocytopenia
    Lambert, Michele P.
    HAMOSTASEOLOGIE, 2019, 39 (03): : 266 - 271
  • [42] Firefighters and cancer: Where are we and where to now?
    Fritschi, Lin
    Glass, Deborah C.
    OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 2014, 71 (08) : 525 - 526
  • [43] Combination therapy in dyslipidemia: Where are we now?
    Catapano, Alberico L.
    Farnier, Michel
    Foody, JoAnne M.
    Toth, Peter P.
    Tomassini, Joanne E.
    Brudi, Philippe
    Tershakovec, Andrew M.
    ATHEROSCLEROSIS, 2014, 237 (01) : 319 - 335
  • [44] Second-Line Therapies in Metastatic Urothelial Carcinoma
    Narayanan, Sujata
    Harshman, Lauren C.
    Srinivas, Sandy
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2015, 29 (02) : 341 - +
  • [45] Pasireotide and Pegvisomant Combination Treatment in Acromegaly Resistant to Second-Line Therapies: A Longitudinal Study
    Chiloiro, Sabrina
    Bima, Chiara
    Tartaglione, Tommaso
    Giampietro, Antonella
    Gessi, Marco
    Lauretti, Liverana
    Anile, Carmelo
    Colosimo, Cesare
    Rindi, Guido
    Pontecorvi, Alfredo
    De Marinis, Laura
    Bianchi, Antonio
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2019, 104 (11): : 5478 - 5482
  • [46] Hormone therapies and venous thromboembolism: where are we now?
    Vlieg, A. van Hylckama
    Middeldorp, S.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 (02) : 257 - 266
  • [47] Current systemic therapies for psoriasis: Where are we now?
    Yamauchi, PS
    Rizk, D
    Kormeili, T
    Patnaik, R
    Lowe, NJ
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2003, 49 (02) : S66 - S77
  • [48] Second-line chemotherapy in advanced biliary cancer: the present now will later be past
    Vivaldi, C.
    Fornaro, L.
    Cereda, S.
    Aprile, G.
    Santini, D.
    Silvestris, N.
    Lonardi, S.
    Leone, F.
    Milella, M.
    Brandi, G.
    Vasile, E.
    ANNALS OF ONCOLOGY, 2014, 25 (12) : 2443 - 2444
  • [49] Second-line pancreatic cancer therapy: Patterns of care and survival.
    Hoang, S. N.
    Hoverman, J. R.
    Turnwald, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [50] Second-Line Therapy for Gemcitabine-Refractory Pancreatic Cancer : Is There a Standard?
    Almhanna, Khaldoun
    Kim, Richard
    ONCOLOGY-NEW YORK, 2008, 22 (10): : 1176 - 1183
12345